期刊文献+

抗原肽处理相关运载体637A/C多态与代谢综合征的关联性研究 被引量:1

Study on the association between polymorphism of TAP1 637 A/G alleles polymorphism and metabolic syndrome
原文传递
导出
摘要 目的探索抗原肽处理相关运载体(TAP1)637A/G多态与代谢综合征(MS)的相关性。方法应用病例对照研究设计,以社区基础上的MS138例(男68例,女70例,年龄61.31岁±11.00岁)和同样来源的162例健康对照(男74例,女88例,年龄48.73岁±11.66岁)进行比较分析,等位基因分型应用限制性片段长度多态性-PCR(RFLP-PCR)方法,多因素调整应用非条件logistic回归模型。结果对照组TAP1 637A/G等位基因频率分别为83.3%、16.7%,符合Hardy-Weinberg平衡(χ^2=1.46,P〉0.05);病例组TAP1 637G等位基因型频率(26.1%)显著高于对照组(16.7%)(P=0.005)。以频率较低的等位基因型(G)为突变型,对于隐性模型和相加模型,经年龄调整,病例组的GG基因型频率分布均显著高于对照组(P〈0.05)。隐性模型:OR:6.62,95%CI:1.73~25.31;相加模型:OR=1.56,95%CI:1.01~2.41;而对于显性模型,两者差异无统计学意义(OR=1.33,95%CI:0.78~2.28)。不同基因型之间MS临床指标比较结果显示,收缩压和舒张压差异有统计学意义(P〈0.05),而血糖、体重指数及血脂等其他特征比较,差异均无统计学意义(P〉0.05)。结论TAP1 637等位基因A〉G改变或基因型AA〉GG与AG〉GG改变可增加MS危险,尤其是增加收缩压和舒张压的水平。 Objective To explore the effect of the transporter 1 associated with antigen processing (TAP1) gene 637 A/G polymorphism on the risk of metabolic syndrome(MS). Methods A case-control study was conducted on 138 based-community patients (68 males and 70 females, 61.31 ± 11.00 years old) diagnosed as MS with 162 healthy subjects(74 males and 88 females, 48.73 ± 11.66 years old) came from the same origin as cases. The allele polymorphisms TAP1 637 A/G was examined by the specificity restriction fragmentlength polymorphism-polymerase chain reaction(RFLP-PCR) method with genomic DNA. The effect of TAP1 637 A/G polymorphisms on MS were analyzed by multivariable unconditional logistic regression models. Results The TAP1 637 A/G allele genotypes frequencies(83.3% ,16.7%) contribution in control group were consistent with the distribution predicted by Hardy-Weinberg equilibrium (χ^2 = 1.46, P 〉 0.05 ). TAP1 637 G allele genotypes frequencies (26.1% ) of cases were significantly higher than controls( 16.7 % ) with P = 0. 005. There were significant differences of AA (58.0 % ), AG (31.9%) and GG(10.1%) genotypes in cases than controls, AA(68.5%). AG(29.6%) and GG ( 1.9 % ) for recessive model and addictive model after age was adjusted with P value as 0. 006 and 0. 044, but no significant differences for dominant model ( P = 0. 298). Results from recessive model with OR = 6.62,95 % CI : 1.73-25.31, Addictive model with OR = 1.56,95 % CI : 1.01-2.41 and one-way ANOVA analysis showed that systolic blood pressure(SBP) and diastolic blood pressure (DBP) levels of GG genotype were significandy higher than AA or AG genotype ( P 〈 0.05 ) whereas no significantly statistical differences for other clinical characteristics. Conclusion The TAP1 637 allele A to G alteration or genotype AA to GG and AG to GG alterations could increase the risk of MS significantly, especially for SBP and DBP levels, and this positive association results might be helpful to support the biological role of TAP1 in MS but in need of larger sample size to provide more powerful evidences.
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2007年第3期286-289,共4页 Chinese Journal of Epidemiology
基金 卫生部科学研究基金(WKJ2004-2-014) 江苏省资源生物重点实验室开放基金(Kjs03043).感谢中国疾病预防控制中心病毒病预防控制所董小平研究员、韩俊老师的大力支持与帮助
关键词 代谢综合征 抗原肽处理相关运载体 多态性 Metabolic syndrome Transporters associated with antigen processing Allele polymorphism
  • 相关文献

参考文献15

  • 1Higgins CF. ABC transporters: from microorganisms to man.Annu Rev Cell Biol, 1992,8 : 67-113.
  • 2Srinivasan KN, Pugalendi KV, Sambandam G, et al. Comparison of glycoprotein components, tryptophan, lipid peroxidation and antioxidants in borderline and severe hypertension and myocardial infarction. Clin Chim Acta, 1998,275:197-203.
  • 3Agata Kubaszek, Anu Markkanen, Johan GE, et al. The association of the K121Q polymorphism of the plasma cell glycoprotein-1 gene with type 2 diabetes and hypertension depends on size at birth. J Clin Endocrinol Metab,2004,89:2044-2047.
  • 4中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3076
  • 5Saeki H, Kuwata S, Nakagawa H, et al. Analysis of diseaseassociated amino acid epitopes on HLA class Ⅱ molecules in atopic dermatitis. J Allergy Clin Immunol, 1995, 96 : 1061-1068.
  • 6Anand SS, Yi QL, Gerstein H, et al. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease.Circulation, 2003,108:4202-4251.
  • 7Whang DH, Park H, Roh EY, et al. TAP1 and TAP2 gene polymorphisms and HLA-TAP haplotypes in Koreans based on 90 families. Hum Immunol, 2005, 66: 998-1007.
  • 8Faucz FR, Probst CM, Petzl-Erler ML. Polymorphism of LMP2, TAP1, LMP7 and TAP2 in Brazilian Amerindians and Caucasoids: implications for the evolution of allelic and haplotypic diversity. EurJ Immunogenet, 2000, 27:5-16.
  • 9Ozbas-Gerceker F, Ozguc M. Frequencies of TAP1 and TAP2 gene polymorphisms in the Anatolian population. Eur J Immunogenet, 2003, 30:97-99.
  • 10苏虹,王保龙,高萍,李向培,叶冬青.皖籍汉族正常人群TAP等位基因多态性分析[J].中国免疫学杂志,2000,16(12):671-672. 被引量:4

二级参考文献33

  • 1胡兴,张振钧,杨珏琴,姚芳娟,范丽安.人类组织相容抗原免疫遗传与妊高征发病关系的探讨[J].中华妇产科杂志,1994,29(11):654-656. 被引量:12
  • 2朱乃硕,黄啸宇,王福庆,陈诗书.中国汉族人群抗原肽运载体(TAP)基因结构的多态性及其在类风湿关节炎易感性中的意义[J].中华微生物学和免疫学杂志,1996,16(5):309-312. 被引量:14
  • 3Trowsdale J, Ragoussis J, Campbell RD. Map of the human MHC[J]. Immunol Today, 1991,12(12):443-446.
  • 4James M, Jamie R, Anthony WP. TAP genes and immunity[J]. Curr Opin Immunol, 2004,16(5):651-659.
  • 5Pascale B, Natalio G, Frank M, et al. HLA-DM, HLA-DO and tapasin: functional similarities and difference[J].Curr Opin Immunnol, 2002,14(1):22-29.
  • 6Mattius PL, Ihde D, Piazza A, et al. New approaches to the population genetics and aggregation analysis of the HLA system, In: Terasaki Pl ed. Histocompatibility Testing[M].Munksgaard Copenhagen, 1980:193-195.
  • 7Wang FQ, Semana G, Fauchet R, et al. HLA-DR and-DQ genotyping by PCR-SSO in Shanghai Chinese[J]. Tissue Antigens, 1993,41(5):223-226.
  • 8Djilali-Saiah I, Benini V, Daniel S, et al. Linkage disequilibrium between HLA class Ⅱ(DR, DQ, DP) and antigen processing( LMP, TAP, DM) genes of the major histocompatibility cumplex[J]. Tissue Antigens, 1997,48(2):87-92.
  • 9Takeuchi F, Nakano K, Matsuta K, et al. Polymorphism of TAP1 and TAP2 in Japanese patients with rheumatoid arthritis[J]. Tissue Antigens, 1997,49(3 Pt 1):280-282.
  • 10Barron KS, Reveille JD, Carrington M, et al. Susceptibility to Re-ither's syndrome is associated with alleles of TAP genes[J]. Arthritis Rheum, 1995,38(5):684-689.

共引文献3096

同被引文献13

  • 1Wu Y. Overweight and obesity in China [ J ]. BMJ, 2006, 333(7564) :362.
  • 2Dietz WH, Robinson TN. Overweight children and adoles- cents[J]. N Engl J Med,2005,352(20) :2100.
  • 3Hung CC,Pirie F, Luan J, et al. Studies of the peptide YY and neuropeptide Y2 receptor genes in relation to human o- besity and obesity-related traits [ J ]. Diabetes, 2004, 53 (9) :2461.
  • 4Neary MT, Batterham RL. Gut hormones: implications for the treatment of obesity [ J ]. Pharmacol Ther, 2009, 124 (1) :44.
  • 5Duca FA,Sakar Y, Covasa M. The modulatory role of high fat feeding on gastrointestinal signals in obesity [J]. J Nutr Biochem ,2013,24(10) : 1663.
  • 6Papadimitriou MA, Krzemien AA, Hahn PM, et al. Peptide YY (3-36)-induced inhibition of food intake in female monkeys [ J ]. Brain Res ,2007 , 1175:60.
  • 7Sileno AP, Brandt GC, Spann BM, et al. Lower mean weight after 14 days intravenous administration peptide YY3-36 ( PYY3-36 ) in rabbits [ J ]. Int J Obes ( Lond ) , 2006,30 (1):68.
  • 8Rahardjo GL, Huang XF, Tan YY, et al. Decreased plasma peptide YY accompanied by elevated peptide YY and Y2 receptor binding densities in the medulla oblongata of diet- induced obese mice [ J ]. Endocrinology, 2007,148 ( 10 ) : 4704.
  • 9Ma L, Tataranni PA, Hanson RL, et al. Variations in pep- tide YY and Y2 receptor genes are associated with severe obesity in Pima Indian men [ J]. Diabetes, 2005,54 ( 5 ) : 1598.
  • 10陈客宏,曾灵,顾玮,黄苏娜,刘庆,蒋建新.利用生物信息学技术挑选TLR2基因标签单核苷酸多态性位点[J].基础医学与临床,2010,30(3):242-245. 被引量:5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部